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Abstract
Background Children with aortic coarctations (CoA) are
increasingly percutaneously treated. Good visualisation of
the CoA is mandatory and can be obtained with three-di-
mensional rotational angiography (3DRA). This study aims
to compare the diagnostic and therapeutic additional value
of 3DRA with conventional biplane angiography (CA) in
children with a CoA.
Methods Patients undergoing percutaneous treatment of
CoA with balloon angioplasty (BA) or stent between 2003
and 2015, were retrospectively reviewed on success rate,
complications, radiation and technical settings. Diagnostic
quality of CA and 3DRA and additional value of 3DRA
were scored.
Results In total, 134 patients underwent 183 catheterisa-
tions, 121 CA and 62 3DRA-guided. Median age was
0.52 years in the BA group and 11.19 years in the stent
group. 3DRA was superior to CA in displaying the left
ventricle (p = 0.008), ascending aorta (p < 0.001), aortic
arch (p = 0.005) and coronary arteries (p < 0.001). In the
BA group, 3DRA had a significantly higher success rate
than CA (100.0 % versus 68.9 %, p = 0.016). All stent
interventions were successful. Complication rates did not
differ significantly. The median total dose area product did
not significantly differ between CA and 3DRA in the BA
(27.88 μGym2/kg versus 15.81 μGym2/kg, p = 0.275) or
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stent group (37.34 μGym2/kg versus 45.24 μGym2/kg, p =
0.090). 3DRA was of additional value in 96.8 % of the
interventions.
Conclusions 3DRA is superior to CA in diagnostic qual-
ity and not associated with increased radiation exposure.
It provides high additional value in guiding CoA related
interventions.
Keywords Three-dimensional imaging · Angiography ·
Aortic coarctation · Endovascular procedures ·
Paediatrics · Congenital heart defects
Introduction
Coarctation of the aorta (CoA) is increasingly being treated
with percutaneous interventions, as it is equally as safe
and effective as surgery [1–5]. Detailed visualisation of
the heart, great vessels and surrounding structures is key to
a successful intervention [6–8]. However, traditional con-
ventional biplane angiography (CA) only provides a two-
dimensional image of the patient’s anatomy [6, 7, 9].
Three-dimensional rotational angiography (3DRA) pro-
duces three-dimensional (3D) images and may provide
more detailed information [6, 7, 9]. Furthermore, the 3D-
image generated can be used as a 3D-roadmap for guiding
interventions [6, 7, 9].
Since 3DRA is a relatively new imaging technique in the
paediatric cardiac catheterisation laboratory, the available
literature on this subject is limited. Previously conducted
studies have mainly focused on radiation dose reduction [8,
10, 11] and fail to directly compare diagnostic accuracy and
therapeutic success between CA and 3DRA. Furthermore,
relatively small and heterogeneous populations were stud-
ied [7, 9]. Therefore, the aim of this study is to evaluate the
Neth Heart J (2016) 24:666–674 667
Table 1 Baseline characteristics of the patients






Males 37 (60.7) 8 (53.3) 0.605
Native coarctation, yes 4 (6.6) 3 (20.0) 0.134
Recurrent coarctation, yes 57 (93.4) 12 (80.0) 0.134
Medical history
– Coarctation 14 (23.0) 3 (20.0) 1.000
– Hypoplastic left heart syndrome or hypoplastic aorta 30 (49.2) 10 (66.7) 0.224
– Interrupted aortic arch 11 (18.0) 2 (13.3) 1.000
– Other 6 (9.8) 0 (0.0) 0.592
Age (years) 0.60 (0.28–1.26) 0.32 (0.25–2.91) 0.493
Height (cm) 68.00 (60.00–80.50) 61.00 (52.00–91.00) 0.518
Weight (kg) 7.40 (5.00–10.00) 5.70 (4.70–12.90) 0.724
Systolic blood pressure right arm (mm Hg) 117.35 ± 15.34 111.92 ± 23.99 0.467
Diastolic blood pressure right arm (mm Hg) 63.98 ± 13.16 58.33 ± 10.63 0.173
Maximum CW Doppler velocity in DAO (m/s) 3.84 ± 0.74 3.30 ± 0.66 0.020
Invasive gradient across the CoA under general anaesthesia
(mm Hg)
22.50 (13.25–40.00) 25.00 (10.00–35.00) 0.591
Diameter of CoA (mm) 3.90 (2.70–5.20) 4.90 (3.80–6.80) 0.090
Non-CoA related diagnostic or interventional procedures
performed, yes






Males 26 (60.5) 17 (63.0) 0.834
Native coarctation, yes 17 (39.5) 10 (37.0) 0.834
Recurrent coarctation, yes 26 (60.5) 17 (63.0) 0.834
Medical history
– Coarctation 30 (69.8) 18 (66.7) 0.786
– Hypoplastic left heart syndrome or hypoplastic aorta 9 (20.9) 8 (29.6) 0.409
– Interrupted aortic arch 1 (2.3) 1 (3.7) 1.000
– Other 3 (7.0) 0 (0.0) 0.279
Age (years) 9.10 (3.43–13.34) 12.82 (8.78–14.76) 0.045
Length (cm) 141.00 (91.00–157.00) 150.00 (135.00–170.00) 0.101
Weight (kg) 32.80 (14.00–47.80) 44.50 (32.00–55.00) 0.098
Systolic blood pressure right arm (mm Hg) 127.78 ± 16.26 133.59 ± 19.02 0.194
Diastolic blood pressure right arm (mm Hg) 66.94 ± 11.65 73.81 ± 13.07 0.055
Maximum CW Doppler velocity in DAO (m/s) 3.35 ± 0.63 3.24 ± 0.68 0.359
Invasive gradient across the CoA under general anaesthesia
(mm Hg)
19.50 (12.25–33.25) 20.00 (13.00–30.00) 0.523
Diameter of CoA (mm) 7.50 (3.88–9.33) 8.10 (4.30–9.80) 0.403
Non-CoA related diagnostic or interventional procedures
performed, yes
12 (27.9) 10 (37.0) 0.423
Medical history of coarctation indicates any medical history in which a CoA was the main diagnosis
CW continuous wave, DAO descending aorta
diagnostic and therapeutic additional value of 3DRA com-
pared with CA in percutaneous treatment of children with
a CoA. In addition, technical settings of 3DRA are analysed
to develop an imaging protocol for optimal visualisation of
a CoA at the lowest achievable radiation dose.
Methods
Study population
This retrospective study analysed CA and 3DRA-guided
cardiac catheterisations that were performed in CoA pa-
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tients at the Wilhelmina Children’s Hospital, University
Medical Center Utrecht between January 2003 and Decem-
ber 2015. All children who underwent cardiac catheterisa-
tion for aortic arch interventions were included. For design-
ing the 3D-imaging protocol all children who underwent
a 3DRA run during a diagnostic or interventional catheteri-
sation were included. The institutional medical ethics com-
mittee provided a waiver for this study.
Data collection
Demographic, clinical and catheterisation data and tech-
nical settings of the 3DRA were retrospectively obtained
from patient files, cardiac catheterisation database (File-
maker Pro 11), and image databases (Xcelera 4.1, OsiriX
MD 2.6 and Siemens syngoDynaCT).
Fluoroscopy films were included in the analysis, but still
frames were excluded. Diagnostic angiographies were de-
fined as all images with contrast displaying relevant car-
diac compartments and vessels. Interventional angiogra-
phies were defined as all images with contrast displaying
balloons or stents and post-interventional control images.
In diagnostic angiographies, visibility of the left ventricle,
aorta, coronary arteries and ostium of the left subclavian
artery was scored on a 3-point scale. Good image quality
was defined as providing a clear delineation of cardiovas-
cular structures, moderate image quality as providing an es-
timated delineation and poor image quality as providing no
delineation. Image quality was determined by the primary
researcher and in case of doubt by paediatric cardiologists
(GK and/or JB).
Therapeutic success was defined as a post-interventional
systolic gradient across the CoA under general anaesthe-
sia of <20 mm Hg [12]. Complications were collected in
accordance with guidelines [13]. Radiation is reported as
dose area product (DAP), which is defined as the product of
radiation dose and exposed patient surface [11]. Two pae-
diatric cardiologists (GK and JB) determined the additional
value of 3D-images compared with CA images according
to a 5-point scale, ranging from essential to misleading [6,
7].
Data analysis
To analyse radiation, fluoroscopy time and number of an-
giographies performed, three groups were created: patients
with sole diagnostic CAs, both diagnostic CAs and 3DRAs
and only diagnostic 3DRAs. Diagnostic quality was anal-
ysed in the full population, as this is not influenced by the
subsequent type of intervention. Further analyses were per-
formed in patients undergoing either balloon angioplasty
(BA) or single stent implantation to enhance comparabil-
ity. Patients receiving multiple stent implantations were
excluded.
3DRA runs of perfect diagnostic quality without arte-
facts, with the exception of stent artefacts, were used to
design the 3D-imaging protocol. Patients with incomplete
data sets were excluded.
Data are presented as frequency with percentages of to-
tal, mean with standard deviation (SD) or median with in-
terquartile range (IQR). Chi-square and Fisher’s exact tests
were used to compare dichotomous variables. Unpaired
two-tailed T-tests and Mann-Whitney U tests were used to
compare normally and non-normally distributed continuous
variables respectively. A p-value <0.05 was considered sta-




In total, 134 patients underwent 183 catheterisations. Sixty-
seven patients underwent BAs, 61 CAs (80.3 %) and 15
3DRAs (19.7 %). Sixty-four patients received stents, 43
CAs (61.4 %) and 27 3DRAs (38.6 %). Median age was
0.52 years in the BA group and 11.19 years in the stent
group (p < 0.001). In the BA group, maximum Doppler
velocity in the descending aorta was significantly lower in
the 3DRA group (p = 0.020). In the stent group, the 3DRA
group were significantly older (p = 0.045) (Table 1).
Diagnostic value
3DRA was superior in displaying the left ventricle, as-
cending aorta, aortic arch and coronary arteries. 3DRA
displayed the descending aorta and ostium of the left sub-
clavian artery equally as well as CA (Fig. 1). Artefacts
were significantly more frequently encountered in 3DRAs
(25.8 %) than in CAs (5.1 %) (p < 0.001). In the 3DRA
group, artefacts were mostly caused by catheter movements
(N = 7 (43.8 %)) due to placement of the angiographic
catheter in the ascending aorta (N = 5) or aortic arch (N =
1).
Therapeutic value
In the BA group, the 3DRA group had a significantly higher
success rate than the CA group: 100.0 % versus 68.9 % re-
spectively (p = 0.016). All stent interventions were suc-
cessful. In the BA group, there was a trend towards lower
median residual gradients in the 3DRA than in the CA
group (9.00 mm Hg versus 13.00 mm Hg, p = 0.087). In
the stent group, systolic and diastolic blood pressure were
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Fig. 1 Image quality of relevant cardiovascular structures with CA and 3DRA. Overview of the image quality per cardiac compartment or vessel.
The p-values display the difference between CA and 3DRA per image quality category
Table 2 Results of the interventions






Successful, yes 42 (68.9) 15 (100.0) 0.016
Systolic blood pressure right arm (mm Hg) 103.85 ± 16.37 109.08 ± 22.83 0.382
Diastolic blood pressure right arm (mm Hg) 60.77 ± 11.28 56.42 ± 9.49 0.220
Maximum CW Doppler velocity in DAO (m/s) 2.81 ± 0.55 2.56 ± 0.47 0.128
Invasive gradient across the CoA under general anaesthesia
(mm Hg)
13.00 (6.75–24.25) 9.00 (3.75–13.00) 0.087
Diameter of CoA (mm) 5.20 (4.15–6.60) 5.70 (4.94–7.78) 0.367






Successful, yes 41 (100.0) 27 (100.0) NA
Systolic blood pressure right arm (mm Hg) 116.31 ± 14.89 128.17 ± 12.95 0.002
Diastolic blood pressure right arm (mm Hg) 63.10 ± 11.33 69.04 ± 10.35 0.044
Maximum CW Doppler velocity in DAO (m/s) 2.56 ± 0.62 2.52 ± 0.59 0.774
Invasive gradient across the CoA under general anaesthesia
(mm Hg)
3.00 (0.00–5.75) 2.50 (0.00–6.50) 0.947
Diameter of CoA (mm) 11.30 (9.00–13.00) 11.20 (9.00–13.80) 0.851
Procedural duration (min) 132.00 (89.00–153.00) 140.00 (105.00–195.00) 0.103
CW continuous wave, DAO descending aorta, NA not applicable
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Table 3 Radiation exposure












8.82 (3.35–15.00) 9.07 (7.27–25.39) 0.284 8.54 (3.25–26.44) 0.734 0.514
CA
(μGym2/kg)d
7.34 (1.97–18.55) 5.28 (1.36–9.42) 0.469 1.30 (0.55–10.26) 0.089 0.433
3DRA
(μGym2/kg)d
6.96 (4.64–11.79)e 8.61 (6.71–14.06) 0.396 5.97 (3.01–8.16) 0.462 0.151
Total
(μGym2/kg)
27.88 (16.12–44.11) 22.52 (16.17–45.09) 0.736 15.81 (6.97–44.70) 0.275 0.361
Fluoroscopy
time (min)










12.85 (10.04–21.99) 17.85 (11.15–30.06) 0.614 15.17 (11.84–34.65) 0.243 0.961
CA
(μGym2/kg)d
13.10 (7.95–19.56) 12.38 (4.47–37.82) 0.850 6.56 (2.84–10.18) 0.042 0.145
3DRA
(μGym2/kg)d
NA 22.31 (8.11–34.71) NA 22.17 (15.23–30.54) NA 0.923
Total
(μGym2/kg)
37.34 (25.93–59.77) 48.90 (36.04–107.25) 0.072 45.24 (37.78–81.34) 0.090 0.923
Fluoroscopy
time (min)
16.10 (11.38–20.28) 23.90 (15.20–35.80) 0.011 20.40 (13.90–36.80) 0.047 0.771
aP-value that indicates the difference between CA and CA and 3DRA.
bP-value that indicates the difference between CA and 3DRA.
cP-value that indicates the difference between CA and 3DRA and 3DRA.
d These subgroups only became available from September 2011.
e The DAP for 3DRA in the CA group was due to post-interventional 3DRA runs.
DAP dose area product, NA not applicable.
significantly higher in the 3DRA than in the CA group (p =
0.002 and p = 0.044 respectively) (Table 2).
Complications
In the BA group, procedural complications occurred in
8 CA catheterisations (13.1 %) versus 4 3DRA catheterisa-
tions (26.7 %) (p = 0.238) and interventional complications
in 18 CA catheterisations (29.5 %) versus 3 3DRA catheter-
isations (20.0 %) (p = 0.538). In the stent group, procedural
complications occurred in 15 CA catheterisations (34.9 %)
versus 7 3DRA catheterisations (25.9 %) (p = 0.432) and in-
terventional complications in 1 CA catheterisation (2.3 %)
versus 0 3DRA catheterisations (p = 1.000). Additional
Table 4 displays the different types of complications.
Angiographies and radiation
3DRA was associated with fewer additional interventional
CAs in both the BA and stent group. This difference was
significant for the A-plane angiographies in the stent group
(p = 0.021). In the BA group, the median total number of
additional CAs was 6.00 (4.00–8.00) in the CA, and 2.00
(0.50–2.00) in the 3DRA group (p = 0.001). In the stent
group, this was 16.00 (12.00–18.00) in the CA, and 8.00
(4.00–9.50) in the 3DRA group (p < 0.001) (Additional
Table 5).
In the BA group, all DAPs were lower in the 3DRA than
in the CA group. In the stent group, DAP due to additional
angiographies was significantly lower in the 3DRA than in
the CA group (p = 0.042) (Table 3).
Additional value of 3DRA
The additional value of 62 3DRAs in CoA interventions
was evaluated. The scores were as follows: 10 3DRAs
were essential (16.1 %), 44 very useful (71.0 %), 6 use-
ful (9.7 %), 2 not useful (3.2 %) and 0 misleading (0.0 %).
Not useful 3DRAs were of poor diagnostic quality due to
suboptimal settings of the 3DRA. The greatest benefit of
3DRA was the ability to fully understand aortic arch and
CoA morphology (N = 60 (96.8 %)) (Fig. 2). Other bene-
fits were the possibility of displaying other cardiovascular
structures (N = 17 (27.4 %)) and vascular anomalies (N = 17
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Fig. 2 Understanding coarc-
tation morphology with 3DRA.
A 17.5-year-old patient with
aortic arch hypoplasia made
visible with a cranial view from
the 3DRA (b), but not with the
lateral view (a), which led to
stenting of the transverse aortic
arch (c,d)
(27.4 %)) in the same run (Fig. 3). In univentricular heart
patients, 3DRA was useful in displaying vessel-vessel or
vessel-bronchi interactions (N = 5 (8.1 %)) (Fig. 3).
Live fluoroscopy overlay of the 3D-reconstructed image
(iPilot) was used in 43 catheterisations (69.4 %). The iPilot
was very helpful in correctly positioning guidewires and
devices. No anatomy shifts occurred due to insertion of stiff
wires. However, small discrepancies between the vessel and
device did occur (N = 6 (14.0 %)).
Learning curve
The total number of 3DRA-guided CoA catheterisations in-
creased from 12 in 2012 to 23 in 2015. Conversely, the me-
dian total DAP strongly decreased from 87.06 μGym2/kg to
23.20 μGym2/kg in the BA group and from 90.15 μGym2/kg
to 43.01 μGym2/kg in the stent group.
3D imaging protocol
77 patients received 126 3DRA runs. Two 3DRA runs
were performed for pre- and post-procedural imaging (N =
28), technical difficulties (N = 4) and requirement of re-
intervention (N = 1). Seventy-one 3DRAs were suitable for
designing the imaging protocol (Fig. 4).
Discussion
3DRA is increasingly being used in the catheterisation lab-
oratory [6–11, 14]. However, the available literature is lim-
ited in quantity and diversity. This study aims to evaluate
the diagnostic and therapeutic additional value of 3DRA
compared with CA in the percutaneous treatment of CoAs.
Additionally, an imaging protocol was designed to achieve
3D-images of optimal diagnostic quality with the lowest
radiation dose possible. Overall, 3DRA proved superior
to CA in terms of diagnostic value and comparable to CA
in terms of success, complications and radiation exposure.
The additional value of 3DRA arises primarily from full
understanding of aortic arch and CoA morphology.
Diagnostic value
Image quality of the left ventricle, ascending aorta, aortic
arch and coronary arteries is significantly higher in 3DRA
than in CA. These structures are important for good device
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Fig. 3 Displaying other vascu-
lar and extravascular structures
with 3DRA. The left side dis-
plays a 2.5-year-old patient with
a recurrent coarctation. 3DRA
displayed a dissection on the
anterior (b), lateral (c) and su-
perior view (d), which was not
clearly visible on the CA (a),
leading to the decision of a stent
implantation. The right side dis-
plays a 3.5-year-old patient with
a recoarctation and a univentric-
ular heart. 3DRA displayed an
important interaction between
the coarctation stent (white),
the left pulmonary artery stent
(yellow) and the left bronchus
(green), which can be visualised
from multiple angles (e-h)
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Fig. 4 Workflow of the 3DRA
run. 3DRAs were performed
with Artis Zee biplane (Siemens,
Erlangen, Germany) under
breath hold and rapid pacing
in the right ventricle (N = 58
(90.6 %)). Pacing frequency was
increased from 160 beats/min
upwards to achieve a 50 %
reduction in systolic blood pres-
sure to allow optimal contrast
filling. Maximal zoom and
collimation were applied. The
contrast was diluted to a 2:1
contrast:saline ratio and admin-
istered with a power injector
prior to the compartment of in-
terest; mostly the left ventricle
(N = 58 (81.7 %)). Images were
recorded with a frame rate of
60 frames/s or 30 frames/s (N =
61 (85.9 %))
positioning. Studies with varying areas of interest report di-
agnostic quality rates of 3DRA from 71 to 94 % [8, 9, 14].
The diagnostic quality in this study is even higher at 98.4 %
good image quality of the aortic arch and subclavian artery.
This could be due to consistent use of rapid pacing and
X-ray delay to ensure optimal contrast filling [8, 9, 14]. Im-
age quality was similar in the BA and stent groups despite
the significant age difference. However, 3DRA reconstruc-
tions contain more artefacts than CA. Some artefacts can
be resolved by changing the technical settings of 3DRA
and post-processing. In all other, the dynamic rotational
angiogram is almost always diagnostic.
Therapeutic value
Therapeutic success was high in both the BA and stent
groups. 3DRA-guided BA resulted in lower residual gra-
dients than previously reported (9.00 versus 12.5 mm Hg)
[4, 15] and was superior to CA in our study. This may
be the result of superior diagnostic imaging leading to im-
proved interventional therapy or more aggressive treatment
strategies. Residual gradients after stenting were low and
comparable to other studies in both CA and 3DRA group
[4, 16]. To date, no study we are aware of has performed
similar comparisons.
Interventional complication rates are comparable to
those described elsewhere [4, 13]. Only one stent dislo-
cation occurred in the CA group. One can speculate that
additional 3D-imaging helps to optimise stent sizing and
positioning, thereby reducing the risk of stent dislocation.
Angiographies and radiation
In five years, a threefold decrease in radiation exposure was
accomplished during 3DRA procedures. There were sev-
eral reasons for this: first, technical settings were altered
and frame rate was lowered from 60 to 30 frames/s with-
out disadvantageous effect on image quality. Second, 3D-
images are of superior diagnostic quality which reduces
the need for additional CAs. Third, during the learning
curve, paediatric cardiologists initially performed both CA
and 3DRA, but with increasing knowledge and confidence,
this was abandoned.
The radiation dose in the 3DRA group was not signif-
icantly higher than that in the CA group (p = 0.275 for
BAs; p = 0.090 for stents). This contrasts with the study
from Manica et al., which reported a significantly higher
DAP of a single 3DRA run compared with three CAs in
patients under 45 kg [8]. Total DAPs were comparable to
other studies, which reported median DAPs for various con-
genital heart disease interventions of 3605 μGym2 [11] and
1429.6 μGym2 for CoA stenting [7]. More importantly, we
see a clear decrease in DAP, currently resulting in very low
total DAPs compared with benchmarks (median) of 2000
μGym2 in children between 1–4 years old and 9600 μGym2
in children between 10–15 years old [17]. The remain-
ing radiation difference between BA and stenting is due to
a difference in complexity of the procedure and age and
therefore size of the patients.
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Additional value
3DRA was of additional value in 96.8 % of the interven-
tions, which is similar to other cohorts. However, we found
more essential 3DRAs [6, 7]. This can be caused by ob-
taining more information from 3DRA, as experience with
this technique increases.
The greatest advantage of 3DRA is the ability to fully un-
derstand aortic arch and CoA morphology. 3DRA is able to
visualise the aorta from an infinite number of angles, some
of which are very important, such as the cranioposterior
angle, which are not provided by CA [6–9]. Furthermore,
other vascular and extravascular (e. g. airway) structures
can be visualised simultaneously with a high spatial resolu-
tion [8]. Moreover, iPilots are of great additional value for
guidewire and stent positioning, thereby reducing the need
to perform multiple CAs to guide the procedures [6, 7, 9].
Imaging protocol
We used 3DRA runs of perfect diagnostic quality to design
a 3DRA imaging protocol for CoAs. This is the first prac-
tical guide ever on optimisation of 3DRA and may help
others to start up 3DRA catheterisation laboratories with
faster learning curves.
Limitations
This study is limited by its retrospective nature. In addition,
our learning curve influenced some median values, such as
radiation doses. Finally, scoring of image quality and addi-
tional value of 3DRA cannot be purely objective. However,
we tried to limit the subjectivity by using predefined scores.
Conclusion
3DRA provides rotatable, high spatial resolution 3D-im-
ages of superior diagnostic quality to CA. Furthermore, in-
terventions can be effectively and safely performed without
exposing patients to higher radiation doses. Finally, iPilots
are of additional value in guiding interventions. Therefore,
3DRA should be considered as the standard imaging tech-
nique in percutaneous interventions in CoAs.
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